WHAT WE DO
AT MEDSIR WE ARE DEDICATED TO OFFER THE MOST RELEVANT NEWS ON THE LATEST ADVANCEMENTS IN ONCOLOGY CLINICAL RESEARCH. FIND OUT THE LATEST NEWS ON ONCOLOGY RESEARCH, REGULATORY APPROVALS, EVENTS, SCIENTIFIC CONFERENCES AND MUCH MORE!
It was great to be back at ASCO!
We’re presenting at ASCO 2022!
We enjoyed presenting our work at ESMO BREAST 2022
We’re presenting at ESMO Breast Cancer 2022!
Pembrolizumab may be the new standard of care for RCC with intermediate to high risk of recurrence